In this fascinating episode about novel formulations in psychedelic science, we explore cutting-edge developments in making psychedelic treatments safer and more effective. Key topics include pro-drugs designed for targeted delivery, non-hallucinogenic analogs that maintain therapeutic benefits without intense psychedelic effects, and innovations in dosage control and delivery methods. The discussion also covers the crucial role of the 5HT2A receptor in psychedelic effects, and the importance of balancing scientific advancement with ethical considerations and patient safety.